The Board of Directors of Roivant Sciences Ltd. has authorized a buyback plan on April 2, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.56 USD | +0.91% | -3.22% | -6.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.41% | 7.73B | |
+47.37% | 765B | |
-6.76% | 354B | |
+19.29% | 331B | |
+8.60% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.02% | 164B | |
-2.26% | 162B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd. authorizes a Buyback Plan.